0000899243-21-036569.txt : 20210920
0000899243-21-036569.hdr.sgml : 20210920
20210920142940
ACCESSION NUMBER: 0000899243-21-036569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210908
FILED AS OF DATE: 20210920
DATE AS OF CHANGE: 20210920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BHATIA NAVEEN
CENTRAL INDEX KEY: 0001452171
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 211262921
MAIL ADDRESS:
STREET 1: 823 GREENTREE RD
CITY: PACIFIC PALISADES
STATE: CA
ZIP: 90272
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 800 THIRD AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-08
0
0000948320
LifeMD, Inc.
LFMD
0001452171
BHATIA NAVEEN
823 GREENTREE RD
PACIFIC PALISADES
CA
90272
1
0
0
0
Common Stock
2021-09-15
4
X
0
96349
1.75
A
96349
D
Stock Option (Right to Buy)
7.07
2021-09-08
4
A
0
100000
0.00
A
2021-09-08
2021-09-08
Common Stock
100000
100000
D
Restricted Stock Unit
0.00
2021-09-08
4
A
0
8000
0.00
A
Common Stock
8000
8000
D
Warrant (Right to Buy)
1.75
2021-09-15
4
G
0
96349
0.00
A
2021-09-15
2022-01-12
Common Stock
96349
96349
D
Warrant (Right to Buy)
1.75
2021-09-15
4
X
0
96349
0.00
D
2021-09-15
2022-01-12
Common Stock
96349
0
D
Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the Director received a one-time grant of 8,000 Restricted Stock Units ("RSUs"), vesting quarterly with 25% vesting on September 30, 2021 and the remaining vesting ratably on December 31, 2021, March 31, 2022 and on the earlier of the annual stockholders' meeting or June 30, 2022. The RSUs represent a contingent right to receive one share of Common Stock for each RSU.
Mr. Bhatia received an option to purchase 100,000 shares of Common Stock, at an exercise price of $7.07 per share, as compensation for services to be provided pursuant to a Consulting Agreement dated September 8, 2021.
/s/ Naveen Bhatia
2021-09-20